• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高度近视患者弥漫性脉络膜视网膜萎缩的进展:一项 4 年随访研究。

Progression of diffuse chorioretinal atrophy among patients with high myopia: a 4-year follow-up study.

机构信息

State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

New England College of Optometry, Boston, USA.

出版信息

Br J Ophthalmol. 2021 Jul;105(7):989-994. doi: 10.1136/bjophthalmol-2020-316691. Epub 2020 Aug 22.

DOI:10.1136/bjophthalmol-2020-316691
PMID:32829302
Abstract

AIMS

To investigate the progression pattern of diffuse chorioretinal atrophy (DCA) among Chinese participants with high myopia.

METHODS

This is a longitudinal, non-interventional study. Participants with high myopia, defined as ≤-6 diopters spherical power, were included and followed up for 4 years, and underwent cycloplegic autorefraction, best-corrected visual acuity (BCVA) and fundus photography examinations. Newly established DCA, enlargement of existing DCA and development of other lesions of myopic maculopathy were regarded as DCA progression.

RESULTS

Of the 484 participants with a mean age of 21.5±12.7 years (range, 6.8-69.7 years), 68 eyes (14.0%) showed DCA progression, with 88 lesion changes. The first appearance of DCA was identified in 21 eyes (23.9%). Of 88 eyes with DCA at baseline, 47 eyes (53.4%) showed progression, with 67 lesion changes, including 45 eyes (67.2%) with enlargement of DCA, 17 (25.3%) with a first appearance of lacquer cracks, 4 (6.0%) with development of patchy chorioretinal atrophy and 1 (1.5%) with increased numbers of lacquer cracks. Longer axial length (p<0.001), baseline DCA (p=0.005) and baseline DCA closer to the fovea (p=0.013) predicted DCA progression. Eyes had poorer BCVA at the follow-up if DCA was enlarging (p<0.001) or DCA was closer to the fovea at baseline (p=0.028) after adjusting for age,gender and cataract.

CONCLUSION

Approximately half of the participants with DCA had progression over a 4-year follow-up. Enlargement and newly developed DCA were common progression patterns. Larger areas of DCA and foveal involvement with DCA could be indicators of a worse BCVA later.

摘要

目的

研究中国人高度近视中弥漫性脉络膜视网膜萎缩(DCA)的进展模式。

方法

这是一项纵向、非干预性研究。纳入标准为近视≤-6 屈光度球镜,随访 4 年,行睫状肌麻痹自动验光、最佳矫正视力(BCVA)和眼底照相检查。将新出现的 DCA、已存在的 DCA 扩大和出现其他近视性黄斑病变视为 DCA 进展。

结果

484 名参与者平均年龄为 21.5±12.7 岁(范围 6.8-69.7 岁),68 只眼(14.0%)出现 DCA 进展,共 88 个病变改变。21 只眼(23.9%)首次出现 DCA。88 只基线时存在 DCA 的眼中,47 只(53.4%)出现进展,共 67 个病变改变,包括 DCA 扩大 45 只眼(67.2%)、首次出现漆裂纹 17 只眼(25.3%)、斑状脉络膜视网膜萎缩 4 只眼(6.0%)和漆裂纹增多 1 只眼(1.5%)。更长的眼轴长度(p<0.001)、基线 DCA(p=0.005)和基线 DCA 更靠近黄斑(p=0.013)预测 DCA 进展。调整年龄、性别和白内障后,如果 DCA 扩大(p<0.001)或基线时 DCA 更靠近黄斑(p=0.028),则随访时眼的 BCVA 更差。

结论

大约一半的 DCA 患者在 4 年的随访中出现进展。DCA 扩大和新出现的 DCA 是常见的进展模式。DCA 更大的面积和累及黄斑可预示着 BCVA 更差。

相似文献

1
Progression of diffuse chorioretinal atrophy among patients with high myopia: a 4-year follow-up study.高度近视患者弥漫性脉络膜视网膜萎缩的进展:一项 4 年随访研究。
Br J Ophthalmol. 2021 Jul;105(7):989-994. doi: 10.1136/bjophthalmol-2020-316691. Epub 2020 Aug 22.
2
DIFFUSE CHORIORETINAL ATROPHY IN CHINESE HIGH MYOPIA: The ZOC-BHVI High Myopia Cohort Study.中国人高度近视的弥漫性脉络膜视网膜萎缩:ZOC-BHVI 高度近视队列研究。
Retina. 2020 Feb;40(2):241-248. doi: 10.1097/IAE.0000000000002397.
3
Long-term pattern of progression of myopic maculopathy: a natural history study.近视性黄斑病变进展的长期模式:一项自然史研究。
Ophthalmology. 2010 Aug;117(8):1595-611, 1611.e1-4. doi: 10.1016/j.ophtha.2009.11.003. Epub 2010 Mar 5.
4
Five-year incidence and progression of myopic maculopathy in a rural Chinese adult population: the Handan Eye Study.中国农村成年人群近视性黄斑病变的五年发病率及进展情况:邯郸眼病研究
Ophthalmic Physiol Opt. 2018 May;38(3):337-345. doi: 10.1111/opo.12456.
5
Progression of Myopic Maculopathy in Highly Myopic Chinese Eyes.高度近视中国人群的病理性近视性黄斑病变进展。
Invest Ophthalmol Vis Sci. 2019 Mar 1;60(4):1096-1104. doi: 10.1167/iovs.18-25800.
6
Ten-Year Progression of Myopic Maculopathy: The Beijing Eye Study 2001-2011.《2001-2011 年北京眼研究:近视性黄斑病变的十年进展》。
Ophthalmology. 2018 Aug;125(8):1253-1263. doi: 10.1016/j.ophtha.2018.01.035. Epub 2018 Mar 27.
7
Progression of Myopic Maculopathy during 18-Year Follow-up.近视性黄斑病变 18 年随访进展。
Ophthalmology. 2018 Jun;125(6):863-877. doi: 10.1016/j.ophtha.2017.12.005. Epub 2018 Jan 19.
8
Peripapillary Diffuse Chorioretinal Atrophy in Children as a Sign of Eventual Pathologic Myopia in Adults.儿童周边弥漫性脉络膜视网膜萎缩是成人病理性近视的潜在标志。
Ophthalmology. 2016 Aug;123(8):1783-1787. doi: 10.1016/j.ophtha.2016.04.029. Epub 2016 May 22.
9
Prevalence and risk factors of myopic maculopathy in rural southern China: the Yangxi Eye Study.中国南方农村近视性黄斑病变的患病率及危险因素:阳山眼病研究。
Br J Ophthalmol. 2019 Dec;103(12):1797-1802. doi: 10.1136/bjophthalmol-2018-313057. Epub 2019 Feb 15.
10
Four-Year Progression of Myopic Maculopathy in Children and Adolescents With High Myopia.高度近视儿童和青少年近视性黄斑病变的四年进展
JAMA Ophthalmol. 2024 Mar 1;142(3):180-186. doi: 10.1001/jamaophthalmol.2023.6319.

引用本文的文献

1
Choroidal vascular changes in early-stage myopic maculopathy from deep learning choroidal analysis: a hospital-based SS-OCT study.基于深度学习脉络膜分析的早期近视性黄斑病变脉络膜血管变化:一项基于医院的SS-OCT研究
Eye Vis (Lond). 2024 Aug 6;11(1):32. doi: 10.1186/s40662-024-00398-x.
2
Myopic maculopathy among Chinese children with high myopia and its association with choroidal and retinal changes: the SCALE-HM study.高度近视中国儿童的近视性黄斑病变及其与脉络膜和视网膜变化的关系:SCALE-HM 研究。
Br J Ophthalmol. 2024 May 21;108(5):720-728. doi: 10.1136/bjo-2022-321839.
3
Progression pattern of myopic maculopathy according to the severity of diffuse chorioretinal atrophy and choroidal thickness.
根据弥漫性脉络膜视网膜萎缩和脉络膜厚度的严重程度,近视性黄斑病变的进展模式。
Sci Rep. 2022 Feb 23;12(1):3099. doi: 10.1038/s41598-022-07172-w.
4
Efficacy and safety of Bu Jing Yi Shi tables for high myopia: A protocol of systematic review and meta-analysis.补晶益肾片治疗高度近视的疗效与安全性:一项系统评价与Meta分析方案
Medicine (Baltimore). 2021 Jan 22;100(3):e24130. doi: 10.1097/MD.0000000000024130.